List view / Grid view

Olivia Cavlan (Alchemab)

 

article

Navigating the challenges and opportunities of AI in drug development and personalised medicine

This article is the second part of Drug Target Review’s…

18 July 2023 | By

This article is the second part of Drug Target Review’s Izzy Wood’s discussion with Olivia Cavlan, Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, exploring the role of AI in target discovery, its applications in personalised medicine, and the evolving landscape of pharmaceutical development.

article

Unleashing the power of AI in target discovery and resilience against disease

In this interview Drug Target Review’s Izzy Wood and Olivia…

11 July 2023 | By

In this interview Drug Target Review’s Izzy Wood and Olivia Cavlan, Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, uncover the untapped potential of AI in target discovery. Alchemab’s revolutionary platform aims to identify common antibodies in resilient individuals and uncover the antigens that contribute to their disease-fighting…